Financial Ratios

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE717.30-4.95 (-0.69 %)
PREV CLOSE ( ) 722.25
OPEN PRICE ( ) 736.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17411
TODAY'S LOW / HIGH ( )695.00 745.00
52 WK LOW / HIGH ( ) 6501249
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)23.8414.295.054.7711.18
   CEPS(Rs)30.0419.1610.079.4814.51
   DPS(Rs)0.700.700.700.660.65
   Book NAV/Share(Rs)194.27153.07107.96103.5797.73
   Tax Rate(%)38.2826.3337.1723.7627.62
Margin Ratios
   Core EBITDA Margin(%)10.496.206.987.3910.34
   EBIT Margin(%)10.145.965.666.189.57
   Pre Tax Margin(%)6.373.832.392.216.35
   PAT Margin (%)3.932.821.501.694.60
   Cash Profit Margin (%)4.963.783.003.355.97
Performance Ratios
   ROA(%)4.863.631.331.544.84
   ROE(%)13.8611.424.774.7414.59
   ROCE(%)18.3513.159.5310.3620.56
   Asset Turnover(x)1.241.290.880.921.05
   Sales/Fixed Asset(x)5.865.603.593.143.23
   Working Capital/Sales(x)2.502.843.074.835.08
Efficiency Ratios
   Fixed Capital/Sales(x)0.170.180.280.320.31
   Receivable days82.94106.79109.1191.8562.16
   Inventory Days130.6192.72160.89147.66111.37
   Payable days94.41111.88189.53178.44221.35
Valuation Parameters
   PER(x)32.6064.0491.7924.4537.85
   PCE(x)25.8747.7846.0212.3029.15
   Price/Book(x)4.005.984.291.134.33
   Yield(%)0.090.080.150.570.15
   EV/Net Sales(x)1.592.031.670.691.92
   EV/Core EBITDA(x)14.2029.3720.808.8517.58
   EV/EBIT(x)15.6334.1029.4911.2420.10
   EV/CE(x)1.692.441.380.551.78
   M Cap / Sales1.281.811.380.411.74
Growth Ratio
   Net Sales Growth(%)22.3767.6418.7316.2462.92
   Core EBITDA Growth(%)97.3544.6521.42-16.6480.70
   EBIT Growth(%)108.1676.678.70-24.93102.31
   PAT Growth(%)70.58214.455.93-57.36154.72
   EPS Growth(%)66.83183.035.93-57.36168.74
Financial Stability Ratios
   Total Debt/Equity(x)0.980.780.920.840.49
   Current Ratio(x)2.042.071.501.271.36
   Quick Ratio(x)0.621.440.720.680.59
   Interest Cover(x)2.692.801.731.562.97
   Total Debt/Mcap(x)0.250.130.210.750.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.